EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection of Anti-Platelet Factor 4 Antibodies in Acute and Chronic Thromboembolic Disease—A Pilot Study

Annabell Trunk, Jan Wesche iD, Stella Jacobi, Marina Bruch-Oms iD, Donata Metzler, Eva Herrmann iD, Thomas Thiele iD, Edelgard Lindhoff-Last iD

International Journal of Molecular Sciences · 05.11.2026 · 27 (21) · 9899

DOI: 10.3390/ijms27219899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.11.2026. Verfasst von Annabell Trunk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Coagulation Centre, Cardiology Angiology Centre Bethanien Hospital (CCB), 60389 Frankfurt, Germany. Hauptthemen laut MEDLINE: Platelet Factor 4, Thromboembolism, Autoantibodies. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterogeneous antibodies directed against platelet factor 4 (PF4-Abs) are associated with heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT). Emerging evidence suggests that these antibodies may also occur in other thromboembolic diseases. In this pilot study, we assessed the prevalence of PF4-Abs in patients with acute thromboembolism and in patients with thromboembolic antiphospholipid syndrome (APS), a chronic autoimmune thrombophilia. Forty patients with acute thromboembolism and 43 patients with APS were included. Both heparin-dependent and heparin-independent PF4-Abs were evaluated using multiple assay platforms, including a prototype chemiluminescence assay for heparin-independent PF4-Abs, an anti-PF4/polyanion IgG chemiluminescence assay, a latex agglutination assay detecting anti-PF4/polyanion IgG/IgM/IgA antibodies, an anti-PF4/heparin IgG ELISA, and functional platelet activation tests. Across the different assays, positivity in at least one assay was observed in 27.5% (11/40) of patients with acute thromboembolism and 27.9% (12/43) of patients with APS. In most antibody-positive patients, no recent heparin exposure was documented. Functional platelet activation was predominantly absent, arguing against a classical HIT- or VITT-like mechanism. Overall, these results demonstrate assay-dependent PF4-Ab positivity in a substantial proportion of patients with acute and chronic thromboembolic conditions. Their clinical and pathogenic relevance remains unclear and warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Factor 4ThromboembolismAutoantibodiesHumansPilot ProjectsFemaleMaleMiddle AgedChronic DiseaseAcute DiseaseAdultHeparinAgedAntiphospholipid SyndromePlatelet ActivationImmunoglobulin G

Stichwörter der Autor:innen

anti-platelet factor 4 antibodiesanti-platelet factor 4/heparin antibodiesanti-platelet factor 4/polyanion antibodiesantiphospholipid syndrome (APS)heparin-induced thrombocytopenia (HIT)immunothrombosisthrombosisvaccine-induced immune thrombocytopenia and thrombosis (VITT)

Substanzen

Platelet Factor 4AutoantibodiesHeparinPF4 protein, humanImmunoglobulin G

Autor:innen und Institutionen

  • Coagulation Centre, Cardiology Angiology Centre Bethanien Hospital (CCB), 60389 Frankfurt, Germany.
  • Coagulation Research Centre Bethanien Hospital, 60389 Frankfurt, Germany.
  • Institute for Transfusion Medicine, University Hospital Greifswald, 17475 Greifswald, Germany.
  • Werfen, 08186 Lliçà d'Amunt, Barcelona, Spain.
  • Goethe University Frankfurt, Institute of Biostatistics and Mathemical Modelling, 60590 Frankfurt, Germany.

ORCID-Profile: Jan Wesche, Marina Bruch-Oms, Eva Herrmann, Thomas Thiele, Edelgard Lindhoff-Last

Zitieren

APA

Trunk, A., Wesche, J., Jacobi, S., Bruch-Oms, M., Metzler, D., Herrmann, E., Thiele, T., & Lindhoff-Last, E. (2026). Detection of Anti-Platelet Factor 4 Antibodies in Acute and Chronic Thromboembolic Disease—A Pilot Study. International Journal of Molecular Sciences, 27(21), 9899. https://doi.org/10.3390/ijms27219899

Vancouver

Trunk A, Wesche J, Jacobi S, Bruch-Oms M, Metzler D, Herrmann E, et al. Detection of Anti-Platelet Factor 4 Antibodies in Acute and Chronic Thromboembolic Disease—A Pilot Study. International Journal of Molecular Sciences. 2026;27(21):9899. doi:10.3390/ijms27219899

BibTeX
@article{Trunk2026,
  author = {Trunk, Annabell and Wesche, Jan and Jacobi, Stella and Bruch-Oms, Marina and Metzler, Donata and Herrmann, Eva and Thiele, Thomas and Lindhoff-Last, Edelgard},
  title = {Detection of Anti-Platelet Factor 4 Antibodies in Acute and Chronic Thromboembolic Disease—A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9899},
  doi = {10.3390/ijms27219899}
}
Kostenlos starten →